Literature DB >> 31925527

Afferent innervation of the ischemic kidney contributes to renal dysfunction in renovascular hypertensive rats.

Nathalia R Lopes1, Maycon I O Milanez1, Beatriz S Martins1, Amanda C Veiga1, Giovanna R Ferreira1, Guiomar N Gomes1, Adriana C Girardi2, Polliane M Carvalho3, Fernando N Nogueira3, Ruy R Campos1, Cássia T Bergamaschi1, Erika E Nishi4,5.   

Abstract

The ablation of renal nerves, by destroying both the sympathetic and afferent fibers, has been shown to be effective in lowering blood pressure in resistant hypertensive patients. However, experimental studies have reported that the removal of sympathetic fibers may lead to side effects, such as the impairment of compensatory cardiorenal responses during a hemodynamic challenge. In the present study, we evaluated the effects of the selective removal of renal afferent fibers on arterial hypertension, renal sympathetic nerve activity, and renal changes in a model of renovascular hypertension. After 4 weeks of clipping the left renal artery, afferent renal denervation (ARD) was performed by exposing the left renal nerve to a 33 mM capsaicin solution for 15 min. After 2 weeks of ARD, we found reduced MAP (~ 18%) and sympathoexcitation to both the ischemic and contralateral kidneys in the hypertensive group. Moreover, a reduction in reactive oxygen species was observed in the ischemic (76%) and contralateral (27%) kidneys in the 2K1C group. In addition, ARD normalized renal function markers and proteinuria and podocin in the contralateral kidney. Taken altogether, we show that the selective removal of afferent fibers is an effective method to reduce MAP and improve renal changes without compromising the function of renal sympathetic fibers in the 2K1C model. Renal afferent nerves may be a new target in neurogenic hypertension and renal dysfunction.

Entities:  

Keywords:  Afferent renal denervation; Proteinuria; Renovascular hypertension; Sympathetic nervous system

Mesh:

Year:  2020        PMID: 31925527     DOI: 10.1007/s00424-019-02346-4

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  29 in total

1.  The amplitude and periodicity of synchronized renal sympathetic nerve discharges in anesthetized cats: differential effect of baroreceptor activity.

Authors:  S C Malpas; I Ninomiya
Journal:  J Auton Nerv Syst       Date:  1992-10

2.  O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats.

Authors:  Rodrigo Pacheco Silva-Aguiar; Nathália C F Bezerra; Miguel C Lucena; Gabriela M Sirtoli; Roberto T Sudo; Gisele Zapata-Sudo; Christina M Takiya; Ana Acacia S Pinheiro; Wagner Barbosa Dias; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2018-06-28       Impact factor: 5.157

3.  Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension.

Authors:  R E Katholi; P L Whitlow; S R Winternitz; S Oparil
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

4.  Increased sympathetic nerve activity in renovascular hypertension.

Authors:  M Johansson; M Elam; B Rundqvist; G Eisenhofer; H Herlitz; G Lambert; P Friberg
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

5.  Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats.

Authors:  Erika Emy Nishi; Elizabeth Barbosa Oliveira-Sales; Cássia T Bergamaschi; Thais Galvão César Oliveira; Mirian A Boim; Ruy R Campos
Journal:  Am J Hypertens       Date:  2010-02-25       Impact factor: 2.689

6.  A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin.

Authors:  Jason D Foss; Richard D Wainford; William C Engeland; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-19       Impact factor: 3.619

7.  Forebrain renin-angiotensin system has a tonic excitatory influence on renal sympathetic nerve activity.

Authors:  Shun-Guang Wei; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

Review 8.  Microalbuminuria and cardiovascular disease.

Authors:  Matthew R Weir
Journal:  Clin J Am Soc Nephrol       Date:  2007-02-14       Impact factor: 8.237

9.  Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.

Authors:  Márcio Galindo Kiuchi; George Luiz Marques Maia; Maria Angela Magalhães de Queiroz Carreira; Tetsuaki Kiuchi; Shaojie Chen; Bruno Rustum Andrea; Miguel Luis Graciano; Jocemir Ronaldo Lugon
Journal:  Eur Heart J       Date:  2013-06-20       Impact factor: 29.983

10.  Effects of leptin on sympathetic nerve activity in conscious mice.

Authors:  Donald A Morgan; Fabien Despas; Kamal Rahmouni
Journal:  Physiol Rep       Date:  2015-09
View more
  10 in total

Review 1.  Renal denervation based on experimental rationale.

Authors:  Kenichi Katsurada; Yukako Ogoyama; Yasushi Imai; Kaushik P Patel; Kazuomi Kario
Journal:  Hypertens Res       Date:  2021-09-13       Impact factor: 5.528

2.  Renal Nerve Ablation in Nephritis and Beyond.

Authors:  Kristina Rodionova; Tilmann Ditting; Roland Veelken
Journal:  J Am Soc Nephrol       Date:  2021-10       Impact factor: 14.978

Review 3.  Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.

Authors:  Kaushik P Patel; Kenichi Katsurada; Hong Zheng
Journal:  Circ Res       Date:  2022-05-12       Impact factor: 23.213

4.  Impact of Selective Renal Afferent Denervation on Oxidative Stress and Vascular Remodeling in Spontaneously Hypertensive Rats.

Authors:  Lu-Lu Wu; Yue Zhang; Xiu-Zhen Li; Xin-Li Du; Ying Gao; Jing-Xiao Wang; Xiao-Li Wang; Qi Chen; Yue-Hua Li; Guo-Qing Zhu; Xiao Tan
Journal:  Antioxidants (Basel)       Date:  2022-05-20

5.  Renal Sensory Activity Regulates the γ-Aminobutyric Acidergic Inputs to the Paraventricular Nucleus of the Hypothalamus in Goldblatt Hypertension.

Authors:  Maycon I O Milanez; Amanda C Veiga; Beatriz S Martins; Roberto B Pontes; Cassia T Bergamaschi; Ruy R Campos; Erika E Nishi
Journal:  Front Physiol       Date:  2020-12-15       Impact factor: 4.566

6.  Whole-Mount Kidney Clearing and Visualization Reveal Renal Sympathetic Hyperinnervation in Heart Failure Mice.

Authors:  Chao Wu; Fang Yan; Min Li; Yimin Tu; Ziyu Guo; Yufei Chen; Yaxin Wu; Qing Li; Changan Yu; Yi Fu; Meihui Wu; Wei Kong; Yanxiang Gao; Xiaowei Li; Jingang Zheng
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

7.  Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats.

Authors:  José Wilson N Corrêa; Karoline R Boaro; Letícia B Sene; Juliano Z Polidoro; Thiago A Salles; Flavia L Martins; Lusiane M Bendhack; Adriana C C Girardi
Journal:  Front Physiol       Date:  2021-06-09       Impact factor: 4.566

8.  Dysregulation of the Excitatory Renal Reflex in the Sympathetic Activation of Spontaneously Hypertensive Rat.

Authors:  Chao Ye; Fen Zheng; Jing-Xiao Wang; Xiao-Li Wang; Qi Chen; Yue-Hua Li; Yu-Ming Kang; Guo-Qing Zhu
Journal:  Front Physiol       Date:  2021-06-03       Impact factor: 4.566

9.  Effects of Renal Denervation on the Enhanced Renal Vascular Responsiveness to Angiotensin II in High-Output Heart Failure: Angiotensin II Receptor Binding Assessment and Functional Studies in Ren-2 Transgenic Hypertensive Rats.

Authors:  Zuzana Honetschlägerová; Lucie Hejnová; Jiří Novotný; Aleš Marek; Luděk Červenka
Journal:  Biomedicines       Date:  2021-11-30

10.  Responsiveness of afferent renal nerve units in renovascular hypertension in rats.

Authors:  Kristina Rodionova; Karl F Hilgers; Salman Rafii-Tabrizi; Johannes Doellner; Nada Cordasic; Peter Linz; Anna-Lena Karl; Christian Ott; Roland E Schmieder; Mario Schiffer; Kerstin Amann; Roland Veelken; Tilmann Ditting
Journal:  Pflugers Arch       Date:  2021-07-07       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.